Medicare Enrolled
Dr. Behzad Taghizadeh, M.D.
Cardiovascular Disease · San Diego, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Taghizadeh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Taghizadeh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Taghizadeh
Dr. Behzad Taghizadeh is a cardiovascular disease specialist in San Diego, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Taghizadeh performed 5,683 Medicare services across 1,435 unique beneficiaries.
Between the years covered by Open Payments, Dr. Taghizadeh received a total of $8,256 from 48 pharmaceutical and/or device companies across 305 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Taghizadeh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 15% volume in CA
$8,256 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,683
Medicare services
Top 15% in CA for cardiovascular disease
1,435
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~284 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
994 | $33 | $84 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
913 | $39 | $101 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
669 | $42 | $105 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
653 | $45 | $115 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
621 | $140 | $379 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
607 | $51 | $132 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
226 | $11 | $50 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
182 | $107 | $272 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
147 | $156 | $430 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
128 | $157 | $437 |
| Radiofrequency vein destruction, first vein A procedure to treat the first incompetent vein in the arm or leg using radiofrequency energy and imaging guidance. |
93 | $933 | $3,610 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
65 | $16 | $44 |
| New patient office visit, complex (60-74 min) | 58 | $180 | $462 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
55 | $98 | $244 |
| Laser vein destruction with imaging guidance This procedure uses laser energy to destroy a faulty vein in the arm or leg. Imaging guidance is used to ensure accurate placement during the treatment. |
40 | $864 | $2,200 |
| Ultrasound-guided injection into a single leg vein A chemical agent is injected into one incompetent vein in the leg while using ultrasound to guide the needle placement. |
35 | $1,190 | $3,070 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
33 | $117 | $336 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
30 | $62 | $175 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
23 | $171 | $435 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
22 | $138 | $421 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
19 | $18 | $46 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
19 | $12 | $31 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
17 | $380 | $999 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
17 | $21 | $71 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
17 | $782 | $1,946 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.3% high complexity
9.6% medium
88.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,256
Total received (2018-2024)
Avg $1,179/year across 7 years
Top 31% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
305
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,256 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$612
2023
$884
2022
$1,485
2021
$2,157
2020
$623
2019
$1,135
2018
$1,360
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$121
Novo Nordisk Inc
$119
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$95
Novartis Pharmaceuticals Corporation
$61
E.R. Squibb & Sons, L.L.C.
$41
Boston Scientific Corporation
$38
PFIZER INC.
$32
Abbott Laboratories
$30
Tactile Systems Technology Inc
$23
Bayer Healthcare Pharmaceuticals Inc.
$20
Lexicon Pharmaceuticals, Inc.
$17
Amgen Inc.
$15
Top 3 companies account for 54.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$888
Janssen Pharmaceuticals, Inc
$853
AstraZeneca Pharmaceuticals LP
$718
Otsuka America Pharmaceutical, Inc.
$372
Boston Scientific Corporation
$349
PFIZER INC.
$348
Abbott Laboratories
$346
E.R. Squibb & Sons, L.L.C.
$316
Boehringer Ingelheim Pharmaceuticals, Inc.
$314
Amgen Inc.
$266
Medtronic, Inc.
$266
GlaxoSmithKline, LLC.
$245
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$238
Vascular Insights, LLC
$221
La Jolla Pharmaceutical Company
$217
Novo Nordisk Inc
$195
Actelion Pharmaceuticals US, Inc.
$191
CVRx, Inc.
$188
Merck Sharp & Dohme Corporation
$151
ABIOMED
$133
Biocompatibles, Inc.
$127
United Therapeutics Corporation
$125
PORTOLA PHARMACEUTICALS, INC.
$125
Merck Sharp & Dohme LLC
$123
Genentech USA, Inc.
$117
Otsuka Pharmaceutical Development & Commercialization, Inc.
$100
BOSTON SCIENTIFIC CORPORATION
$98
Braemar Manufacturing, LLC
$90
SANOFI-AVENTIS U.S. LLC
$70
Tactile Systems Technology Inc
$56
Impulse Dynamics (USA) Inc.
$38
Kiniksa Pharmaceuticals, Ltd.
$34
Kowa Pharmaceuticals America, Inc.
$31
Lexicon Pharmaceuticals, Inc.
$31
CathWorks, Inc.
$30
Terumo Medical Corporation
$26
iRhythm Technologies, Inc.
$25
Chiesi USA, Inc.
$23
Trevena, Inc.
$23
Medtronic Vascular, Inc.
$22
Antares Pharma, Inc.
$22
Regeneron Healthcare Solutions, Inc.
$21
AngioDynamics, Inc.
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
ViiV Healthcare Company
$19
CMP Pharma, Inc.
$11
Bard Peripheral Vascular, Inc.
$9
Venclose Inc.
$6
Top 3 companies account for 29.8% of all-time payments
Associated products mentioned in payments ›
ACCOLADE · ACCOLADE SR · AVEIR · Arcalyst · Assurity Pacemaker · BEVYXXA · BREZTRI · BRILINTA · Barostim Neo System · CABENUVA · CAMZYOS · CHANTIX · CONFIRM RX · Cardiac Monitoring Suite · CardioMEMS HF System · CaroSpir · Clarivein · Confirm Rx · ELIQUIS · ENTRESTO · EVRSF · FARXIGA · FFRangio · FLEXITOUCH · Flexitouch Plus · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · GIAPREZA · General - Therapies · HeartMate 3 Left Ventricular Assist Device · Impella · Inpefa · JARDIANCE · JYNARQUE · KENGREAL · Kerendia · LATITUDE · LEQVIO · LINQ II · LUX DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MICRA · MITRACLIP · MULTAQ · Micra · Mitra Clip system · MitraClip System · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · OTREXUP · Olinvyk · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Quadra Assura CRT Defibrillator · Repatha · Reveal LINQ · SAMSCA · TRELEGY ELLIPTA · UPTRAVI · VADO · VARITHENA · VERQUVO · VYNDAMAX · WATCHMAN · WATCHMAN Access System · XARELTO · Xolair · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
239
Per 100K population
7.3
County median income
$102,285
Nearest hospital
KAISER FOUNDATION HOSPITAL - SAN DIEGO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Taghizadeh is a clinical cardiology specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Taghizadeh experienced with remote vital sign monitoring management, each additional 20 minutes?
Based on Medicare claims data, Dr. Taghizadeh performed 994 remote vital sign monitoring management, each additional 20 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Taghizadeh receive payments from pharmaceutical companies?
Yes. Dr. Taghizadeh received a total of $8,256 from 48 companies across 305 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Taghizadeh's costs compare to other cardiologists in San Diego?
Dr. Taghizadeh's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Taghizadeh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in San Diego
Browse cardiologists in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology